Multistate Outbreak of Poisonings Associated With Illicit Use of Gamma Hydroxy Butyrate

JAMA: The Journal of the American Medical Association

Volumn 265, Issue 4, 1991, Pages 447-448

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

OXYBATE SODIUM; 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; ANALGESIC AGENT; BENZODIAZEPINE; HALOPERIDOL; NALOXONE; NARCOTIC AGENT; NEUROLEPTIC AGENT;

ARTICLE; EMERGENCY; EPIDEMIC; HEALTH SURVEY; HUMAN; INTOXICATION; UNITED STATES; DRUG TOXICITY; GASTROINTESTINAL DISEASE; HEALTH CARE POLICY; NEUROTOXICITY; PRIORITY JOURNAL; SHORT SURVEY;

DISEASE OUTBREAKS; EMERGENCIES; HUMAN; POISONING; POPULATION SURVEILLANCE; SODIUM OXYBATE; UNITED STATES;

EID: 0026023374     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1991.03460040021006     Document Type: Article

References (5)

1. Food and Drug Administration. Gamma hydroxybutyric acid (Press release). Rockville, Md: Food and Drug Administration, November 8, 1990.
2. Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM. Eosinophilia-myalgia syndrome: results of national surveillance. JAMA 1990;264:1698-703.
3. Vayer P, Mandel P, Maitre M. Minireview: gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 1987;41:1547-57.
4. Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev 1989;13:187-98.
5. United States Pharmaceutical Convention, Inc. USP dispensing information. Vol IB. Drug information for the health care professional, 1990:2914.